Your browser doesn't support javascript.
loading
Drug updates and approvals: 2019 in review.
Crump, Lauren Hartsell; Benfield, Miranda; Ramey, Caleb; Arcara, Ashley; Yang, Sebin; Brown, Jenna; Mospan, Geoffrey; Mospan, Cortney.
Affiliation
  • Crump LH; Lauren Hartsell Crump is a PGY-1 pharmacy resident at Novant Health Presbyterian Medical Center, Charlotte, N.C. Miranda Benfield is a PGY-1 pharmacy resident at Carolinas Medical Center, Charlotte, N.C. Caleb Ramey is a PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Ashley Arcara is a PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Sebin Yang is a PharmD candidate at Wingate University School of Pharmacy, Wingate, N.C. Jenna Brown is a PharmD c
Nurse Pract ; 44(12): 21-32, 2019 Dec.
Article in En | MEDLINE | ID: mdl-31658218
In 2019, the FDA approved several new drugs for use in primary care. This article highlights the following new drugs: risankizumab-rzaa (Skyrizi); halobetasol and tazarotene (Duobrii); dolutegravir and lamivudine (Dovato); romosozumab-aqqg (Evenity); brexanolone (Zulresso); solriamfetol (Sunosi); aclidinium and formoterol (Duaklir Pressair); and siponimod (Mayzent).
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval Limits: Humans Country/Region as subject: America do norte Language: En Journal: Nurse Pract Year: 2019 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval Limits: Humans Country/Region as subject: America do norte Language: En Journal: Nurse Pract Year: 2019 Document type: Article Country of publication: Estados Unidos